<DOC>
	<DOCNO>NCT00282867</DOCNO>
	<brief_summary>The purpose study assess feasibility , safety preliminary efficacy use insulin infusion treatment hyperglycemic acute ischemic stroke patient .</brief_summary>
	<brief_title>Glucose Regulation Acute Stroke Patients ( GRASP ) Study</brief_title>
	<detailed_description>Ischemic stroke common , devastate costly disease . Half acute stroke patient elevate glucose level upon admission hospital , hyperglycemia associate poor outcome post-stroke patient . It unclear treatment hyperglycemia glucose lower improves outcome , however , animal stroke model human condition , aggressive glucose lower beneficial . The goal multicenter trial determine tight control blood glucose beneficial hyperglycemic patient acute ischemic stroke . In trial , researcher compare intravenous ( IV ) glucose insulin potassium ( GIK ) therapy plus meal insulin control therapy 72 stroke patient . Participants randomly assign one three groups— ( 1 ) control group target glucose level &lt; 300mg/dL ; ( 2 ) tight control GIK plus meal insulin group target &lt; 110mg/dL ; ( 3 ) loose control GIK plus meal insulin group target &lt; 200mg/dL—with group avoid glucose level &lt; 70mg/dL . The specific aim study collect preliminary data safety feasibility GIK treatment hyperglycemia acute stroke patient , collect preliminary data compare tight GIK therapy loose GIK therapy control therapy . Information learn study compliment ongoing work allow maximum efficiency design future treatment trial .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>18 year age old . Clinical diagnosis ischemic stroke define acute neurological deficit occur one major vessel . Must arrive hospital able begin treatment within 2 hour establish eligibility must within 24 hour symptom onset . Patients unable report symptom onset time awaken symptom must use time last know well onset time . Admission plasma glucose &gt; 110 mg/dL . Renal dysfunction define serum creatinine &gt; /=2.5 mg/dL enrollment . Substantial preexist neurological psychiatric illness would confound neurological assessment . Patients receive experimental therapy enrollment stroke . Pregnant female . Patients severe life threatening condition make unlikely survive 90 day . Patients unable follow protocol come back 90day followup . Patient condition insulin infusion usual practice treat physician feel indication insulin infusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stroke</keyword>
	<keyword>acute ischemic stroke</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>glucose</keyword>
	<keyword>insulin</keyword>
	<keyword>insulin potassium therapy</keyword>
	<keyword>GIK</keyword>
</DOC>